RHHVF

ABBV AMGN AMGN:CA BAYRY BAYZF Biotechnology BMY GILD IPSEF IPSEY JNJ JNJ:CA LLY LLY:CA NONOF NOVO:CA NVO NVON:CA NVS NVS:CA NVSEF PFE PFE:CA REGN RHHBF RHHBY RHHVF Robert J. Lake ROCH:CA ROG:CA SAN:CA SNY SNY:CA SNYNF Uncategorized VRTX ZLLY:CA ZPFE:CA

Regeneron: Fairly Valued Now After A Stellar Upswing

Mar 11, 2026

Biotechnology BMY BMYMP CELG.RT NONOF NOVO:CA NVO NVON:CA PRTA RHHBF RHHBY RHHVF ROCH:CA ROG:CA Terry Chrisomalis Uncategorized

Prothena: A Hold With 2 Late-Stage Programs Underway But With Caution

Mar 3, 2026

Biotechnology BYDDF ESLOF GALDY GVDBF HDLMY HLBZF LIN LNVGF LNVGY MHVYF MTD RHHBF RHHBY RHHVF RYAOF SDVKF SFGYY TKOMF TKOMY TT Uncategorized UNCFF UNCRY ZLAB

ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025

Feb 4, 2026